-
1.
公开(公告)号:WO2019126593A1
公开(公告)日:2019-06-27
申请号:PCT/US2018/066970
申请日:2018-12-20
申请人: TRANSLATE BIO, INC.
发明人: ASKEW, Kim , CHUNG, Jou-ku , DEROSA, Frank , HEARTLEIN, Michael , KARVE, Shrirang , MCCAULEY, Thomas , SMITH, Lianne , BARBIER, Ann, J.
CPC分类号: A61K48/005 , A61K9/0019 , A61K9/1272 , A61K38/45 , A61K47/6929 , A61K48/0025 , A61K48/0075 , A61K48/0083 , A61P3/00 , C12N15/52 , C12N15/85 , C12Y201/03003
摘要: The present invention provides, among other things, methods of treating ornithine transcarbamylase deficiency, including administering to a subject in need of treatment a composition comprising an mRNA encoding an ornithine transcarbamylase protein at a low dose and at an administration interval such that at least one symptom or feature of the OTC deficiency is reduced.